Microbiology & Infectious Diseases

New research explores how virus-specific T-cell therapy may help prevent or treat cytomegalovirus after transplant, revealing high response rates in HSCT patients but limited data in solid organ recipients.

The targeted use of local antibiotics in orthopedic surgery is gaining traction, but limited supporting evidence continues to challenge its widespread adoption, according to a new review exploring current practices and novel technologies in infection management.

New 20-year study reveals that rare CNS infections in kidney transplant recipients carry high mortality and long-term neurological impact, with metagenomic sequencing crucial for diagnosis.

Pregnancy alters the immune system, increasing susceptibility to infections like Pneumocystis jirovecii, an opportunistic fungus known for causing severe pneumonia in immunocompromised individuals.

Fecal microbiota transplantation (FMT), an emerging therapy for conditions like irritable bowel syndrome (IBS), continues to raise questions about the safety of transferring certain microorganisms, especially the intestinal parasite Blastocystis spp.

Pseudomonas aeruginosa, a leading cause of microbial keratitis, continues to challenge clinicians with rising antimicrobial resistance.

Clostridioides difficile infection (CDI) remains a pressing challenge in older adults, particularly those with comorbidities, leading to significant mortality and healthcare costs.

Each flu season, influenza quietly inflicts a heavy toll on U.S. adults aged 18 to 64, with hospitalizations and deaths mounting, especially among older adults and those with chronic conditions.